Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David Hong

Showing results (131-140 of 272) with videos related to

Pageof 28
Sort By:
Cancer|June 8, 2012
Safety, pharmacokinetics, and activity of EZN-2208, a novel conjugate of polyethylene glycol and SN38, in patients with advanced malignanciesRazelle Kurzrock, Sanjay Goel, Jennifer Wheler, et al.
Critical Reviews in Oncology/Hematology|April 22, 2017
FGFR a promising druggable target in cancer: Molecular biology and new drugsRut Porta, Roberto Borea, Andreia Coelho, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 14, 2011
Phase I trial of cixutumumab combined with temsirolimus in patients with advanced cancerAung Naing, Razelle Kurzrock, Angelika Burger, et al.
Science Advances|September 30, 2017
Identification and prioritization of novel anti-<i>Wolbachia</i> chemotypes from screening a 10,000-compound diversity libraryKelly L Johnston, Darren A N Cook, Neil G Berry, et al.
Cancer Chemotherapy and Pharmacology|November 13, 2012
Dose-finding study of hepatic arterial infusion of oxaliplatin-based treatment in patients with advanced solid tumors metastatic to the liverApostolia M Tsimberidou, Mark B Leick, Joann Lim, et al.
Bioorganic Chemistry|March 11, 2022
Novel 18β-glycyrrhetinic acid derivatives as a Two-in-One agent with potent antimicrobial and anti-inflammatory activityBorong Tu, Jinfeng Liang, Yi Ou, et al.
American Journal of Medical Genetics. Part A|August 13, 2025
Generating Advancements in Longitudinal Analysis in X and Y Variations: Rationale, Methods, and Diagnostic Characteristics for the GALAXY RegistryAlexandra Carl, Samantha Bothwell, Karli Swenson, et al.
Frontiers in Chemistry|January 23, 2023
Ligand and structure-based approaches for the exploration of structure-activity relationships of fusidic acid derivatives as antibacterial agentsWende Zheng, Borong Tu, Zhen Zhang, et al.
European Journal of Medicinal Chemistry|July 11, 2024
Design and synthesis of unique indole-benzosulfonamide oleanolic acid derivatives as potent antibacterial agents against MRSAJinxuan Li, Ying Sun, Kaize Su, et al.
Biology|July 27, 2022
Targeting the Ubiquinol-Reduction (Q<sub>i</sub>) Site of the Mitochondrial Cytochrome <i>bc<sub>1</sub></i> Complex for the Development of Next Generation Quinolone AntimalarialsKangsa Amporndanai, Nattapon Pinthong, Paul M O'Neill, et al.
Pageof 28

Showing results (131-140 of 272) with videos related to

Sort By:
Pageof 28
Cancer|June 8, 2012
Safety, pharmacokinetics, and activity of EZN-2208, a novel conjugate of polyethylene glycol and SN38, in patients with advanced malignanciesRazelle Kurzrock, Sanjay Goel, Jennifer Wheler, et al.
Critical Reviews in Oncology/Hematology|April 22, 2017
FGFR a promising druggable target in cancer: Molecular biology and new drugsRut Porta, Roberto Borea, Andreia Coelho, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 14, 2011
Phase I trial of cixutumumab combined with temsirolimus in patients with advanced cancerAung Naing, Razelle Kurzrock, Angelika Burger, et al.
Science Advances|September 30, 2017
Identification and prioritization of novel anti-<i>Wolbachia</i> chemotypes from screening a 10,000-compound diversity libraryKelly L Johnston, Darren A N Cook, Neil G Berry, et al.
Cancer Chemotherapy and Pharmacology|November 13, 2012
Dose-finding study of hepatic arterial infusion of oxaliplatin-based treatment in patients with advanced solid tumors metastatic to the liverApostolia M Tsimberidou, Mark B Leick, Joann Lim, et al.
Bioorganic Chemistry|March 11, 2022
Novel 18β-glycyrrhetinic acid derivatives as a Two-in-One agent with potent antimicrobial and anti-inflammatory activityBorong Tu, Jinfeng Liang, Yi Ou, et al.
American Journal of Medical Genetics. Part A|August 13, 2025
Generating Advancements in Longitudinal Analysis in X and Y Variations: Rationale, Methods, and Diagnostic Characteristics for the GALAXY RegistryAlexandra Carl, Samantha Bothwell, Karli Swenson, et al.
Frontiers in Chemistry|January 23, 2023
Ligand and structure-based approaches for the exploration of structure-activity relationships of fusidic acid derivatives as antibacterial agentsWende Zheng, Borong Tu, Zhen Zhang, et al.
European Journal of Medicinal Chemistry|July 11, 2024
Design and synthesis of unique indole-benzosulfonamide oleanolic acid derivatives as potent antibacterial agents against MRSAJinxuan Li, Ying Sun, Kaize Su, et al.
Biology|July 27, 2022
Targeting the Ubiquinol-Reduction (Q<sub>i</sub>) Site of the Mitochondrial Cytochrome <i>bc<sub>1</sub></i> Complex for the Development of Next Generation Quinolone AntimalarialsKangsa Amporndanai, Nattapon Pinthong, Paul M O'Neill, et al.
Pageof 28